pharma · Multiple Myeloma · generalized myasthenia gravis · RNAC
Cartesian Therapeutics
Cartesian Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 7495 New Horizon Way, Frederick, Maryland 21703, US
- Founded
- 2016
- Employees
- 89
- Programs
- 12
- Drugs
- 4
- Patents
- 4
Cartesian Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Cartesian Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Cartesian Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Cartesian Therapeutics.
-
Descartes-08 — Phase 2
Clinical update -
Descartes-08 — Phase 2
Clinical update -
Descartes-08 — Phase 2
Clinical update -
Placebo to Descartes-08, Descartes-08 — Phase 3
Clinical update -
Descartes 30 — Phase 1
Clinical update -
Descartes-25 — Phase 1
Clinical update -
Descartes-15 — Phase 1
Clinical update -
Descartes-11 — Phase 2
Clinical update